North Run Capital’s Momenta Pharmaceuticals MNTA Stock Holding History
Bought
Maintained
Sold
Other funds holding MNTA
North Run Capital's MNTA Position: Q4 2016 in Review
North Run Capital sold out of Momenta Pharmaceuticals (MNTA) in Q4 2016, closing a stake of 705,000 shares — an estimated $8.24M sold.
North Run Capital first reported a position in MNTA in Q1 2016 and held it in 3 quarters. The position peaked at $8.5M in Q2 2016. 160 funds tracked by Wall St. Rank hold MNTA as of Q4 2016.
- North Run Capital reported no remaining Momenta Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
- North Run Capital sold 705,000 Momenta Pharmaceuticals shares in Q4 2016, an estimated $8.24M.
- North Run Capital first reported a position in Momenta Pharmaceuticals in Q1 2016 and held it in 3 quarters.
- North Run Capital's Momenta Pharmaceuticals position peaked at $8.5M in Q2 2016.
- 160 funds tracked by Wall St. Rank held Momenta Pharmaceuticals as of Q4 2016.
Based on North Run Capital's 13F filing for Q4 2016, filed 10 Feb 2017.